Abstract:Kai Wu, 1, * Qiong Feng, 2, * Liang Li, 1 Yanfei Xiong, 3 Shihong Liu, 4 Jie Liu, 1 Qing Wu 1 1 Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang 300006, People's Republic of China; 2 Nursing School, Nanchang University, Nanchang 300006, People's Republic of China; 3 Department of Orthopedics, Jingan Hospital, Yichun 330600, People's Republic of China; 4 Jingan Hospital of Traditional Chinese Medicine, Yichun 330600, People's Republic of China *These authors contributed equally to this work Correspondence: Qing Wu Email wuqing18186@126.com Introduction: The long-noncoding RNA PCAT6 plays an important regulatory role in the development of several cancers. However, the expression pattern and underlying mechanisms of PCAT6 in osteosarcoma (OS) are yet unknown. Methods: We used real-time PCR to measure PCAT6 expression in 106 tumor pairs and corresponding non-tumor tissues from OS patients. Statistical analyses were applied to evaluate the prognostic value and associations of PCAT6 expression with clinical parameters. Furthermore, the PCAT6 was silenced with siRNA in OS cells. Moreover, phenotype of PCAT6 silenced OS cells was measured using colony formation, CCK-8, cell migration and invasion assay. Finally, the molecular mechanism of PCAT6/miR-143-3p/ZEB1 axis in OS progression was explored. Results: The expression level of PCAT6 in OS tissues was significantly elevated as compared with that in the adjacent normal bone tissues and that high PCAT6 expression closely correlated with the malignant phenotype and poor survival among patients with OS. Multivariate analyses revealed PCAT6 overexpression as an independent prognostic factor for the poor outcome of patients with OS. Functional assay results demonstrated that the knockdown of PCAT6 expression notably suppressed the proliferation, migration, and invasion of OS cells. An elevated PCAT6 level aggravated the malignant phenotype of OS cells via ZEB1 expression upregulation. Mechanistic studies revealed that PCAT6 could sponge endogenous miR-143-3p and inhibit its activity, resulting in an increase in ZEB1 level. Finally, we demonstrated that the tumour-promoting role of PCAT6 in OS was dependent on the regulation of the miR-143-3p/ZEB1 axis. Conclusion: These findings highlight the potential role of PCAT6, which could serve as a valuable prognostic indicator for patients with OS. Keywords: osteosarcoma, PCAT6, ZEB1, miR-143-3p

The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

Clinical Significance and Potential Mechanisms of the RNA Methyltransferase KIAA1429 in Osteosarcoma

RETRACTED ARTICLE: KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p

CircRNA-CIRH1A Promotes the Development of Osteosarcoma by Regulating PI3K/AKT and JAK2/STAT3 Signaling Pathways

LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner

Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9

Long-Noncoding RNA PCAT6 Aggravates Osteosarcoma Tumourigenesis via the MiR-143-3p/ZEB1 Axis

PI3K/Akt signaling in osteosarcoma

KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor

SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling.

MiR-92a modulates proliferation, apoptosis, migration and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3.

Solute Carrier Family 35 Member A2 Regulates Mitophagy Through the PI3K/AKT/mTOR Axis, Promoting the Proliferation, Migration, and Invasion of Osteosarcoma Cells.

The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1

Integrated Genome-Wide Methylation and Expression Analyses Reveal Key Regulators in Osteosarcoma

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value

ACSL4 accelerates osteosarcoma progression via modulating TGF-β/Smad2 signaling pathway